Stan Smith, Director at MAIA Biotechnology, Inc. (MAIA), bought 294,984 shares at $2.03 ($599K) on 2024-04-25, disclosed to the SEC on 2024-04-26.
Open-market purchase of $599k MAIA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.03 | 147,492 | $299K | 50.0% |
| 2 | $2.03 | 147,492 | $299K | 50.0% |
| Total | $2.03 avg | 294,984 | $599K | 100% |
| Filing → |
| MAIA | BUY | 2025-12-23 | $140K | — | Filing → |
| MAIA | BUY | 2025-12-09 | $11K | — | Filing → |
| MAIA | BUY | 2025-12-01 | $16K | — | Filing → |